Zilver PTX Drug-Eluting Peripheral Stent Post-Approval Study

Trial Profile

Zilver PTX Drug-Eluting Peripheral Stent Post-Approval Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral vascular disorders
  • Focus Therapeutic Use
  • Sponsors Cook Medical
  • Most Recent Events

    • 13 Feb 2017 Planned End Date changed from 1 Apr 2021 to 1 Oct 2021.
    • 24 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 04 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top